nimacimab glp-1 news Beyond #obesity": YSM's Jorge Moreno, MD, discussed the potential impact of medications on conditions like #heart disease, #diabetes, kidney disease, and sleep apnea at a recent town hall hosted by South Skye Bioscience's Nimacimab: A Transformative
Description
This affects the refund analysis later in this review
Research has shown that nausea is one of the most frequently reported side effects of GLP-1 drugs, affecting up to 40% of users
If you suspect you are experiencing side effects from any medication, you can report these through the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk
Patchett, A
[2] The safety profile of Orforglipron was consistent with existing GLP-1 therapies, with the most common adverse events being mild to moderate gastrointestinal symptoms such as diarrhea, nausea, dyspepsia, and constipation
doi: 10.1126/sciadv.abg4544
